Quantitative risk reduction through peanut immunotherapy: Assessment for the peanut-allergic population undergoing epicutaneous immunotherapy (EPIT)

被引：0
|
作者：
Remington, B. C. [1 ]
Krone, T. [1 ]
Koppelman, S. J. [2 ]
机构：
[1] TNO, Zeist, Netherlands
[2] Univ Nebraska, Food Allergy Res & Resource Program, Lincoln, NE USA
来源：
ALLERGY | 2018年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
0111
引用
收藏
页码：63 / 63
页数：1
相关论文
共 50 条
  • [1] SERUM BIOMARKERS OF IMMUNOMODULATION DURING PEANUT EPICUTANEOUS IMMUNOTHERAPY (EPIT) IN PEANUT-ALLERGIC SUBJECTS
    Greenhawt, M.
    Carr, W.
    Davis, C.
    Lieberman, J.
    Mustafa, S.
    Green, T.
    Gramme, P.
    Lambert, R.
    Fleischer, D.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (05) : S12 - S12
  • [2] Peanut Epicutaneous Immunotherapy (EPIT) In Peanut-Allergic Children: 18 Months Treatment In The Arachild Study
    Dupont, Christophe
    Bourrier, Thierry
    de Blay, Frederic
    Guenard-Bilbault, Lydie
    Sauvage, Christine
    Cousin, Marie-Odile
    Kanny, Gisele
    Jarlot, Sophie
    Karila, Chantal
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (02) : AB102 - AB102
  • [3] Immune response evolution in peanut epicutaneous immunotherapy for peanut-allergic children
    Bastin, Marie
    Carr, Warner W. W.
    Davis, Carla M. M.
    Fleischer, David M. M.
    Lieberman, Jay A. A.
    Mustafa, S. Shahzad
    Helleputte, Thibault
    Bois, Timothee
    Campbell, Dianne E. E.
    Green, Todd D. D.
    Greenhawt, Matthew
    [J]. ALLERGY, 2023, : 2467 - 2476
  • [4] Epicutaneous Immunotherapy (EPIT) Is Safe for the Treatment of Peanut Allergy in Allergic Patients
    Agbotounou, Wence
    Martin, Laurent
    Dupont, Bertrand
    Pascal, Isabelle
    Vauleon, Cecile
    Benhamou, Pierre Henri
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 131 (02) : AB91 - AB91
  • [5] Treatment of eosinophilic gastritis by epicutaneous immunotherapy (EPIT) in peanut allergic piglets
    Mondoulet, Lucie
    Kalach, Nicolas
    Dhelft, Veronique
    Larcher, Thibaut
    Delayre-Orthez, Carine
    Sampson, Hugh A.
    Benhamou, Pierre-Henri
    Dupont, Christophe M.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (02) : AB48 - AB48
  • [6] Deciphering the dose-response effect of peanut Epicutaneous ImmunoTherapy (EPIT) in peanut allergic subjects
    Dupont, C.
    Agbotounou, W. K.
    Thebault, C.
    Ruban, C.
    Martin, L.
    Yang, W. H.
    Sussman, G. L.
    Brown-Whitehorn, T. F.
    Nadeau, K. C.
    Cheema, A. S.
    Leonard, S. A.
    Pongracic, J. A.
    Sauvage-Delebarre, C.
    Assa'ad, A. H.
    De Blay, F.
    Bird, J. A.
    Tilles, S. A.
    Boralevi, F.
    Bourrier, T.
    Shreffler, W. G.
    Hebert, J.
    Green, T. D.
    van Wijk, Gerk R.
    Knulst, A. C.
    Kanny, G.
    Kowalski, M. L.
    Schneider, L. C.
    Benhamou, P-H
    Sampson, H. A.
    [J]. ALLERGY, 2015, 70 : 117 - 117
  • [7] Epicutaneous Immunotherapy vs Placebo for Peanut Protein Ingestion Among Peanut-Allergic Children
    Zylke, Jody W.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 321 (10): : 956 - 956
  • [8] Peanut-allergic patient experiences after epicutaneous immunotherapy: peanut consumption and impact on QoL
    Lewis, Megan O.
    Brown-Whitehorn, Terri F.
    Cianferoni, Antonella
    Rooney, Courtney
    Spergel, Jonathan M.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (01) : 101 - 103
  • [9] Biomarker assessment after 12 months of peanut epicutaneous immunotherapy (EPIT) for peanut allergy
    Greenhawt, M.
    Fleischer, D. M.
    Green, T. D.
    Lambert, R.
    Robin, B.
    Zinger, C.
    Tilles, S. A.
    [J]. ALLERGY, 2018, 73 : 254 - 255
  • [10] Estimated Risk Reduction to Packaged Food Reactions by Epicutaneous Immunotherapy (EPIT) for Peanut Allergy
    Tomani, Michael
    Bingemann, Theresa
    [J]. PEDIATRICS, 2020, 146 : S354 - S354
12345